NEGATIVE COOPERATIVITY IN THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR AND A CHIMERIC IGF/INSULIN RECEPTOR

被引:65
作者
CHRISTOFFERSEN, CT
BORNFELDT, KE
ROTELLA, CM
GONZALES, N
VISSING, H
SHYMKO, RM
TENHOEVE, J
GROFFEN, J
HEISTERKAMP, N
DEMEYTS, P
机构
[1] UNIV WASHINGTON, DEPT PATHOL, SM30, SEATTLE, WA 98195 USA
[2] UNIV FLORENCE, SCH MED, I-50134 FLORENCE, ITALY
[3] CITY HOPE NATL MED CTR, DEPT DIABET ENDOCRINOL & METAB, DUARTE, CA 91010 USA
[4] CHILDRENS HOSP LOS ANGELES, DEPT PATHOL, MOLEC DIAGNOSIS SECT, LOS ANGELES, CA 90027 USA
关键词
D O I
10.1210/en.135.1.472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin and insulin-like growth factor-I (IGF-I) share a spectrum of metabolic and growth-promoting effects, mediated through homologous receptors that belong to the tyrosine kinase family. The dissociation rate of insulin from its receptor is affected by negative cooperativity, i.e. accelerates with increased receptor occupancy. The dose-response curve for the acceleration of tracer dissociation by unlabeled insulin has a distinct bell-shaped curve, with a progressive slowing down at insulin concentrations greater than 100 nM. The kinetics of the IGF-I interaction with its receptor has not been studied in such detail. In the present work, we report that while the IGF-I receptor exhibits negative cooperativity like the insulin receptor, the concentration dependence of the dissociation kinetics is distinct from that of native human insulin by not being bell-shaped, but monophasic like that of insulin analogues mutated at the hexamer-forming surface; it is changed to an insulin-type curve by substitution of IGF-I receptor's sequence including residues 382-565 with the homologous insulin receptor domain. The data suggest that like insulin, IGF-I has a bivalent binding mode and crosslinks two distinct areas of the two alpha subunits that are close, but distinct from the equivalent insulin receptor binding sites.
引用
收藏
页码:472 / 475
页数:4
相关论文
共 34 条
[1]  
BORNFELDT KE, 1994, IN PRESS J CLIN INVE
[2]  
CARBONNELLE C, 1992, 74TH END SOC ANN M, P326
[3]  
CASELLA SJ, 1986, J BIOL CHEM, V261, P9268
[4]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[5]  
CHRISTOFFERSEN CT, 1993, DIABETES, V42, pA163
[6]  
DEMEYTS P, 1978, NATURE, V273, P504
[7]  
DEMEYTS P, 1976, J BIOL CHEM, V251, P1877
[8]  
DEMEYTS P, 1994, IN PRESS DIABETOLOGI
[9]  
DEMEYTS P, 1993, EXP CLIN ENDOCRINOL, V101, P22
[10]  
DEMEYTS P, 1990, DIABETES, V39, pA234